Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Natalizumab and progressive multifocal leucoencephalopathy Berger JRAnn Rheum Dis 2006[Nov]; 65 Suppl 3 (Suppl 3): iii48-53Current data suggest that as many as 1 in 1000 treated individuals may develop progressive multifocal leucoencephalopathy (PML) in concert with the use of natalizumab. Natalizumab was withdrawn in early 2005. The present paper provides a comprehensive description of PML and reviews the role of natalizumab in the pathogenesis of PML. It is likely that use of drugs which cause specific perturbations of the immune system will be accompanied by similar rare infections. Thus researchers should be on the alert when using such agents in clinical trials.|AIDS-Related Opportunistic Infections/chemically induced/therapy[MESH]|Antibodies, Monoclonal, Humanized[MESH]|Antibodies, Monoclonal/*adverse effects[MESH]|Humans[MESH]|Leukoencephalopathy, Progressive Multifocal/*chemically induced/diagnosis/therapy[MESH]|Multiple Sclerosis, Relapsing-Remitting/drug therapy[MESH]|Natalizumab[MESH]|Opportunistic Infections/*chemically induced/diagnosis/therapy[MESH]|Prognosis[MESH] |